← Leaderboards
John Richard Lee
Weill Medical Coll Of Cornell Univ
$4,485,838
Attributed
$5,186,146
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,186,146 · 6
By mechanism
R01$2,842,000 · 2
R21$1,400,616 · 3
K23$943,530 · 1
Top collaborators
- Iwijn De Vlaminck4 shared
- Hyunyoung Jeong2 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Xin Li$1,438,906
- Amy Lynn Byers$4,815,202
- Melody Y Zeng$4,188,493
- Chun-Jun Guo$9,235,746
- Shuibing Chen$16,196,697
Others in their field
Top investigators on “Specimen”
- Jeffrey P Krischer · University Of South Florida$372,057,923
- Marian Ewell · The Emmes Company, Llc$278,931,253
- David Heimbrook · Leidos Biomedical Research, Inc.$273,257,812
- James Dennis Neaton · Northwestern University$273,164,823
- Judith S. Currier · University Of California Los Angeles$170,089,509
- Barbara Driver · Westat, Inc.$161,528,142
Research focus
SpecimenEnd Stage Renal FailureTransplantationTransplant RecipientsKidney TransplantationGut MicrobiotaBiological MarkersRecruitPreventMetagenomic SequencingMicrobialPilot ProjectsAntibioticsGut MicrobiomeBioinformaticsPharmaceutical PreparationsDiagnosisAcuteBacteriaSecondary AnalysisCellsImmunosuppressive AgentsMicrobiomeBase
Grant awards (15)
Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients$792,245
R01 · FY2025 · AI · contact PI
Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicities$604,993
R01 · FY2025 · DK · contact PI
Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients$796,319
R01 · FY2024 · AI · contact PI
Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicities$648,443
R01 · FY2024 · DK · contact PI
Gut Microbiota and Tacrolimus Trough Variability in Kidney Transplant Recipients$201,725
R21 · FY2024 · AI · contact PI
Gut Microbiota and Tacrolimus Trough Variability in Kidney Transplant Recipients$261,475
R21 · FY2023 · AI · contact PI
Cell-Free DNA in Peritoneal Fluid as a Novel and Versatile Analyte for Monitoring Peritonitis$247,126
R21 · FY2022 · AI · contact PI
Cell-Free DNA in Peritoneal Fluid as a Novel and Versatile Analyte for Monitoring Peritonitis$233,441
R21 · FY2021 · AI · contact PI
Gut Microbiome, Acute Rejection, and Tacrolimus Dosing in Kidney Transplantation$189,177
K23 · FY2020 · AI · contact PI
Gut Microbiome, Acute Rejection, and Tacrolimus Dosing in Kidney Transplantation$190,358
K23 · FY2019 · AI · contact PI
Host-Pathogen Interactions From Measurements of Urinary Cell Free DNA in Kidney Transplantation$208,141
R21 · FY2018 · AI · contact PI
Gut Microbiome, Acute Rejection, and Tacrolimus Dosing in Kidney Transplantation$191,503
K23 · FY2018 · AI · contact PI
Host-Pathogen Interactions From Measurements of Urinary Cell Free DNA in Kidney Transplantation$248,708
R21 · FY2017 · AI · contact PI
Gut Microbiome, Acute Rejection, and Tacrolimus Dosing in Kidney Transplantation$192,618
K23 · FY2017 · AI · contact PI
Gut Microbiome, Acute Rejection, and Tacrolimus Dosing in Kidney Transplantation$179,874
K23 · FY2016 · AI · contact PI